Harbour Investment Management’s GSK GSK Stock Holding History

Harbour Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-26,752	Closed	-$1.29M	–	73
2015 Q3	$1.29M	Sell	26,752 -80	-0.3%	-$4.16K	1.03%	44
2015 Q2	$1.4M	Sell	26,832 -260	-1%	-$14.6K	1.05%	44
2015 Q1	$1.56M	Sell	27,092 -7,064	-21%	-$405K	1.15%	43
2014 Q4	$1.82M	Sell	34,156 -200	-0.6%	-$11.2K	1.15%	36
2014 Q3	$1.97M	Buy	34,356 +2,060	+6%	+$126K	1.31%	29
2014 Q2	$2.16M	Sell	32,296 -384	-1%	-$26K	1.37%	31
2014 Q1	$2.18M	Sell	32,680 -80	-0.2%	-$5.41K	1.43%	27
2013 Q4	$2.19M	Sell	32,760 -2,520	-7%	-$163K	1.46%	26
2013 Q3	$2.21M	Sell	35,280 -372	-1%	-$23.9K	1.54%	24
2013 Q2	$2.23M	Buy	+35,652	New	+$2.26M	1.63%	24

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Harbour Investment Management's GSK Position: Q4 2015 in Review

Harbour Investment Management sold out of GSK (GSK) in Q4 2015, closing a stake of 26,752 shares — an estimated $1.29M sold.

Harbour Investment Management first reported a position in GSK in Q2 2013 and held it in 10 quarters. The position peaked at $2.23M in Q2 2013. 718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

Harbour Investment Management reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
Harbour Investment Management sold 26,752 GSK shares in Q4 2015, an estimated $1.29M.
Harbour Investment Management first reported a position in GSK in Q2 2013 and held it in 10 quarters.
Harbour Investment Management's GSK position peaked at $2.23M in Q2 2013.
718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Harbour Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.